Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HNLGY Hang Lung Group	$8.80 +7.7%	$7.62	$5.28 ▼ $8.80	$7.35B	0.13	77 shs	2,184 shs
JEXYY Jiangsu Expressway	$26.04 -10.2%	$25.92	$18.29 ▼ $29.00	N/A	0.22	66 shs	948 shs
OMRNY Omron	$26.37 -5.1%	$26.84	$24.16 ▼ $47.75	$5.73B	1.04	47,492 shs	36,288 shs
PHMMF Pharma Mar	$92.57	$93.25	$34.26 ▼ $105.60	N/A	0.2	2,486 shs	4,000 shs

10 Stocks Set to Soar in Summer 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HNLGY Hang Lung Group	+7.70%	+7.70%	+20.55%	+33.54%	+55.75%
JEXYY Jiangsu Expressway	-10.21%	-10.21%	+6.55%	+8.36%	+27.09%
OMRNY Omron	-5.11%	+2.59%	+0.42%	-5.70%	-27.38%
PHMMF Pharma Mar	0.00%	0.00%	-11.41%	+4.97%	+170.20%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HNLGY Hang Lung Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
JEXYY Jiangsu Expressway	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OMRNY Omron	2.9971 of 5 stars	0.0	5.0	1.7	0.0	1.9	0.0	2.5
PHMMF Pharma Mar	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HNLGY Hang Lung Group	0.00	N/A	N/A	N/A
JEXYY Jiangsu Expressway	0.00	N/A	N/A	N/A
OMRNY Omron	0.00	N/A	N/A	N/A
PHMMF Pharma Mar	4.00	Strong Buy	N/A	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HNLGY Hang Lung Group	$1.51B	5.25	$0.37 per share	23.47	$20.09 per share	0.44
JEXYY Jiangsu Expressway	N/A	N/A	N/A	N/A	N/A	N/A
OMRNY Omron	$5.26B	1.03	$1.51 per share	17.50	$29.90 per share	0.88
PHMMF Pharma Mar	$189.23M	N/A	$0.41 per share	223.50	$11.62 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HNLGY Hang Lung Group	$276.02M	N/A	0.00	∞	N/A	N/A	N/A	N/A	7/28/2025 (Estimated)
JEXYY Jiangsu Expressway	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	8/27/2025 (Estimated)
OMRNY Omron	$107.39M	$0.56	47.09	16.69	N/A	2.07%	1.75%	1.22%	8/1/2025 (Estimated)
PHMMF Pharma Mar	$28.27M	N/A	0.00	∞	N/A	N/A	N/A	N/A	7/28/2025 (Estimated)

Latest PHMMF, HNLGY, JEXYY, and OMRNY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/8/2025	Q4 2025	OMRNY Omron	$0.4052	$0.30	-$0.1052	$0.30	$1.48 billion	$1.53 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HNLGY Hang Lung Group	$0.79	8.98%	N/A	N/A	N/A
JEXYY Jiangsu Expressway	$1.21	4.65%	N/A	N/A	N/A
OMRNY Omron	$0.61	2.31%	N/A	108.93%	N/A
PHMMF Pharma Mar	N/A	N/A	N/A	N/A	N/A

Latest PHMMF, HNLGY, JEXYY, and OMRNY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/1/2025	JEXYY Jiangsu Expressway		$1.2083	4.17%	7/3/2025	7/4/2025	8/11/2025
5/2/2025	HNLGY Hang Lung Group		$0.3991	7.39%	5/8/2025	5/9/2025	6/26/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HNLGY Hang Lung Group	0.34	0.71	0.71
JEXYY Jiangsu Expressway	N/A	N/A	N/A
OMRNY Omron	0.13	2.31	1.57
PHMMF Pharma Mar	0.20	2.97	2.33

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HNLGY Hang Lung Group	N/A
JEXYY Jiangsu Expressway	N/A
OMRNY Omron	1.09%
PHMMF Pharma Mar	N/A

Insider Ownership

Company	Insider Ownership
HNLGY Hang Lung Group	N/A
JEXYY Jiangsu Expressway	N/A
OMRNY Omron	N/A
PHMMF Pharma Mar	1.88%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HNLGY Hang Lung Group	3,930	899.85 million	N/A	Not Optionable
JEXYY Jiangsu Expressway	4,754	N/A	N/A	Not Optionable
OMRNY Omron	28,450	206.24 million	N/A	Not Optionable
PHMMF Pharma Mar	509	N/A	N/A	Not Optionable

PHMMF, HNLGY, JEXYY, and OMRNY Headlines

Recent News About These Companies

Pharma Mar’s Strategic Shareholder Meeting

June 18, 2025 | tipranks.com

Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Decreases By 78.0%

June 12, 2025 | marketbeat.com

ASCO 25: Jazz, PharmaMar reveal SCLC survival data

May 26, 2025 | pharmaphorum.comP

Exploring High Growth Tech Stocks In Europe May 2025

May 16, 2025 | finance.yahoo.com

Positive Phase IIa dose-ranging study for PharmaMar’s SYL1801

May 13, 2025 | thepharmaletter.comT

Exploring High Growth Tech Stocks in Europe April 2025

April 14, 2025 | finance.yahoo.com

Pharma Mar’s Credit Rating Maintained at ‘BB+’

April 4, 2025 | tipranks.com

Pharma Mar Implements Share Delivery Plan to Boost Employee Engagement

April 2, 2025 | tipranks.com

3 European Growth Stocks With Insider Ownership Seeing Up To 52% Earnings Growth

March 27, 2025 | finance.yahoo.com

Pharma Mar Releases 2024 Director Remuneration Report

February 28, 2025 | tipranks.com

High Insider Ownership Growth Companies To Watch In February 2025

February 21, 2025 | finance.yahoo.com

High Growth Tech Leads These 3 Top Stocks with Potential

February 11, 2025 | finance.yahoo.com

Pharma Mar And 2 Other Stocks That May Be Trading Below Estimated Value

February 4, 2025 | uk.finance.yahoo.com

3 Growth Stocks With Insider Ownership Expecting Up To 71% Earnings Growth

January 23, 2025 | finance.yahoo.com

3 Stocks Estimated To Be Up To 48% Below Intrinsic Value

January 6, 2025 | finance.yahoo.com

Insider-Led Growth Stocks To Watch In December 2024

December 25, 2024 | sg.finance.yahoo.com

Pharma Mar S.A. Reduces Share Capital by Canceling Shares

November 22, 2024 | markets.businessinsider.com

Pharma Mar Achieves Legal Win in Aplidin Case

November 21, 2024 | markets.businessinsider.com

Pharma Mar Hits $10 Million Milestone with Janssen

November 5, 2024 | msn.com

PharmaMar gets $10 million milestone from Janssen for Yondelis

November 5, 2024 | thepharmaletter.comT

New miRNA inhibitor could extinguish the 'inflammatory fire' that stroke causes in the brain

October 28, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHMMF, HNLGY, JEXYY, and OMRNY Company Descriptions

Hang Lung Group OTCMKTS:HNLGY

$8.80 +0.63 (+7.70%)

As of 07/10/2025 01:39 PM Eastern

Hang Lung Group Limited, an investment holding company, operates as a property developer in Hong Kong and the Mainland of China. The company operates through Property Leasing and Property Sales segments. It develops properties for sale and lease, such as large-scale commercial, office, and residential developments. The company also invests in and develops various properties, including shopping malls, office premises, residential and industrial premises, and car parking bays. In addition, its investment properties portfolio includes Grand Gateway 66, a commercial, office, and residential complex, as well as Plaza 66, a commercial and office complex in Shanghai; Palace 66 and Forum 66 in Shenyang; Parc 66 in Jinan; Center 66 in Wuxi; Riverside 66 in Tianjin; Olympia 66 in Dalian; Spring City 66 in Kunming; and Heartland 66 in Wuhan. Further, the company offers car park and property management, financial, management, project management, and property agency services, as well as operates and manages apartment. Hang Lung Group Limited was incorporated in 1960 and is headquartered in Central, Hong Kong.

Jiangsu Expressway OTCMKTS:JEXYY

$26.04 -2.96 (-10.21%)

As of 07/10/2025 01:15 PM Eastern

Jiangsu Expressway Company Limited engages in investment, construction, operation, and management of toll roads and bridges in the People's Republic of China. The company operates the Jiangsu section of Shanghai-Nanjing Expressway, Ningchang Expressway, Zhenli Expressway, Guangjing Expressway, Xicheng Expressway, Xiyi Expressway, Zhendan Expressway, Yanjiang Expressway, Jiangyin Bridge, Sujiahang Expressway, Changyi Expressway, Yichang Expressway, and Wufengshan Bridge. As of December 31, 2022, it operated 17 road and bridge projects; and owned approximately 910 kilometers of roads and bridges. The company also offers passenger transportation; and ancillary services, including refueling, catering, shopping, automobile maintenance, advertising and accommodation, etc. In addition, it engages in the real estate development; and sale of electricity and petroleum products. The company was incorporated in 1992 and is headquartered in Nanjing, China. Jiangsu Expressway Company Limited is a subsidiary of JiangSu Communications Holding Co., Ltd.

Omron OTCMKTS:OMRNY

$26.37 -1.42 (-5.11%)

As of 07/10/2025 03:54 PM Eastern

OMRON Corporation engages in industrial automation, device and module solutions, social systems, and healthcare businesses worldwide. The Industrial Automation Business offers sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products. It also offers environmental mobility, digital devices, food and commodity, logistic and warehouse automation, medical, robotic, panel, vision, software, and traceability related solutions. The Social Systems, Solutions and Service Business provides energy, public transport, traffic safety, network protection, payment, infrastructure monitoring, management service, and DX solutions, as well as offers remote surveillance/monitoring, automation/robotics, software development, engineering/maintenance, and other services. The Healthcare Business provides cardiovascular, respiratory care, pain management, remote patient monitoring, and other solutions. The Device and Module Solutions Business offers relays, switches, connectors, and sensors. OMRON Corporation was founded in 1933 and is headquartered in Kyoto, Japan.

Pharma Mar OTCMKTS:PHMMF

$92.57 0.00 (0.00%)

As of 07/9/2025

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time